No Data
No Data
Express News | Watching Shares Of Terns Pharmaceuticals; Traders Circulating Popular Newsletter Positively Mentioning The Company
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Announces Target Price $10
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $15
Buy Rating for Terns Pharmaceuticals Amid Forthcoming Milestones and Financial Stability
Terns Pharma Analyst Ratings
TD Cowen Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating
No Data